Display options
Share it on

Mol Biol Cell. 2020 Apr 15;31(9):859-865. doi: 10.1091/mbc.E18-10-0668.

Preserving genome integrity in human cells via DNA double-strand break repair.

Molecular biology of the cell

Ryan B Jensen, Eli Rothenberg

Affiliations

  1. Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520-8040.
  2. Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016.

PMID: 32286930 PMCID: PMC7185975 DOI: 10.1091/mbc.E18-10-0668

Abstract

The efficient maintenance of genome integrity in the face of cellular stress is vital to protect against human diseases such as cancer. DNA replication, chromatin dynamics, cellular signaling, nuclear architecture, cell cycle checkpoints, and other cellular activities contribute to the delicate spatiotemporal control that cells utilize to regulate and maintain genome stability. This perspective will highlight DNA double-strand break (DSB) repair pathways in human cells, how DNA repair failures can lead to human disease, and how PARP inhibitors have emerged as a novel clinical therapy to treat homologous recombination-deficient tumors. We briefly discuss how failures in DNA repair produce a permissive genetic environment in which preneoplastic cells evolve to reach their full tumorigenic potential. Finally, we conclude that an in-depth understanding of DNA DSB repair pathways in human cells will lead to novel therapeutic strategies to treat cancer and potentially other human diseases.

References

  1. DNA Repair (Amst). 2013 Aug;12(8):578-87 - PubMed
  2. Nat Commun. 2018 Sep 24;9(1):3882 - PubMed
  3. Mol Cell. 2015 Jun 18;58(6):935-46 - PubMed
  4. Nat Commun. 2019 Aug 9;10(1):3588 - PubMed
  5. EMBO J. 2003 May 1;22(9):2255-63 - PubMed
  6. Mo Med. 2013 Jul-Aug;110(4):314-9 - PubMed
  7. Annu Rev Genomics Hum Genet. 2007;8:37-55 - PubMed
  8. Annu Rev Biochem. 2010;79:181-211 - PubMed
  9. Nature. 2018 Jul;559(7713):279-284 - PubMed
  10. Nature. 2015 May 28;521(7553):541-544 - PubMed
  11. Environ Mol Mutagen. 2000;35(2):71-81 - PubMed
  12. J Biol Chem. 2012 Feb 10;287(7):4936-45 - PubMed
  13. Cancer Res. 1974 Sep;34(9):2311-21 - PubMed
  14. Cell Rep. 2013 Jun 27;3(6):1958-69 - PubMed
  15. Annu Rev Microbiol. 1974;28(0):445-68 - PubMed
  16. DNA Repair (Amst). 2014 May;17:81-97 - PubMed
  17. Expert Opin Investig Drugs. 2017 Dec;26(12):1341-1355 - PubMed
  18. Nucleic Acids Res. 2016 Jun 20;44(11):5256-70 - PubMed
  19. J Biol Chem. 2011 Sep 16;286(37):32638-50 - PubMed
  20. Nature. 2016 Jul 20;535(7612):382-7 - PubMed
  21. Science. 2017 Mar 17;355(6330):1152-1158 - PubMed
  22. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Nov 1;67(Pt 11):1399-402 - PubMed
  23. Annu Rev Genet. 2011;45:247-71 - PubMed
  24. Cancer Res. 2012 Nov 1;72(21):5588-99 - PubMed
  25. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  26. Mutat Res. 2013 Apr-Jun;752(2):138-52 - PubMed
  27. Mol Cancer Ther. 2014 Feb;13(2):433-43 - PubMed
  28. Nat Commun. 2017 Aug 22;8(1):319 - PubMed
  29. Nucleic Acids Res. 2017 Feb 28;45(4):1872-1878 - PubMed
  30. Biochem Soc Trans. 2011 Oct;39(5):1387-92, suppl 2 p following 1392 - PubMed
  31. Mech Ageing Dev. 2008 Jul-Aug;129(7-8):349-52 - PubMed
  32. Nature. 2005 Apr 14;434(7035):917-21 - PubMed
  33. Nucleic Acids Res. 2003 Dec 15;31(24):7238-46 - PubMed
  34. Nat Struct Mol Biol. 2010 Nov;17(11):1305-11 - PubMed
  35. Cancer Discov. 2013 Jan;3(1):68-81 - PubMed
  36. Cell Cycle. 2008 Jan 1;7(1):33-8 - PubMed
  37. Nat Commun. 2017 Sep 13;8(1):525 - PubMed
  38. FEBS J. 2010 Sep;277(17):3470-88 - PubMed
  39. Cell. 2018 May 3;173(4):972-988.e23 - PubMed
  40. Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506 - PubMed
  41. J Clin Oncol. 2017 Apr 20;35(12):1274-1280 - PubMed
  42. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2575-84 - PubMed
  43. Nature. 2005 Apr 14;434(7035):913-7 - PubMed
  44. J Biol Chem. 2007 Nov 2;282(44):31937-43 - PubMed
  45. J Biol Chem. 1997 Dec 19;272(51):31941-4 - PubMed
  46. Nucleic Acids Res. 2009 Jul;37(12):4055-62 - PubMed
  47. J Cell Sci. 2019 Jul 1;132(13): - PubMed
  48. DNA Repair (Amst). 2012 Mar 1;11(3):310-6 - PubMed
  49. Mol Cell. 2017 Sep 7;67(5):867-881.e7 - PubMed
  50. Biochem Cell Biol. 2013 Feb;91(1):31-41 - PubMed
  51. Sci Transl Med. 2016 Oct 26;8(362):362ps17 - PubMed
  52. Cell Rep. 2017 Oct 10;21(2):333-340 - PubMed
  53. Nat Struct Mol Biol. 2018 Oct;25(10):971-980 - PubMed
  54. EMBO J. 1994 Dec 1;13(23):5764-71 - PubMed
  55. PLoS One. 2012;7(1):e30042 - PubMed
  56. Nature. 2008 Feb 28;451(7182):1111-5 - PubMed
  57. J Biol Chem. 2007 Apr 13;282(15):11155-62 - PubMed
  58. J Mol Biol. 1976 Mar 5;101(3):417-25 - PubMed
  59. Clin Cancer Res. 2015 Oct 1;21(19):4257-61 - PubMed
  60. Nucleic Acids Res. 1998 Sep 1;26(17):3944-8 - PubMed
  61. Nucleic Acids Res. 2012 Feb;40(4):1684-94 - PubMed
  62. Cell. 2011 May 13;145(4):529-42 - PubMed
  63. EMBO J. 2002 Jun 17;21(12):3192-200 - PubMed
  64. Trends Biochem Sci. 1995 Oct;20(10):405-11 - PubMed
  65. Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12663-8 - PubMed
  66. Biochimie. 2003 Nov;85(11):1161-73 - PubMed
  67. Nature. 2016 Jul 28;535(7613):566-9 - PubMed
  68. Cancer Treat Rev. 2012 Apr;38(2):89-100 - PubMed
  69. Cell. 2007 Sep 21;130(6):991-1004 - PubMed
  70. Nature. 2018 Aug;560(7716):117-121 - PubMed
  71. Nature. 2008 Feb 28;451(7182):1116-20 - PubMed
  72. Cell. 2006 Jan 27;124(2):301-13 - PubMed
  73. Mol Cell Biol. 2014 Apr;34(8):1380-8 - PubMed
  74. Proteins. 2014 Feb;82(2):187-94 - PubMed
  75. EMBO J. 2008 Jan 9;27(1):290-300 - PubMed
  76. J Cell Biol. 2015 Mar 2;208(5):563-79 - PubMed
  77. Nature. 2010 Oct 7;467(7316):678-83 - PubMed
  78. Nucleic Acids Res. 2012 Feb;40(4):1868-78 - PubMed
  79. Cell Rep. 2017 Sep 19;20(12):2810-2819 - PubMed
  80. Structure. 2010 Nov 10;18(11):1431-42 - PubMed
  81. Mol Cell. 2017 Oct 19;68(2):414-430.e8 - PubMed
  82. Semin Cancer Biol. 2010 Aug;20(4):254-60 - PubMed

Substances

MeSH terms

Publication Types

Grant support